CAR-T manufacturing
CAR-T manufacturing
Revolutionary Partnership Automates Cell Therapy Manufacturing for Age-Related Diseases
🙌 Multiply Labs and Retro Biosciences partner to automate cell therapy manufacturing for age-related diseases, valued at $85 million. 🌍
Revolutionary Automation System Cuts Cell and Gene Therapy Costs by 70
🤖 Vendor-agnostic automation system for cell and gene therapy manufacturing reduces errors and lowers costs.💡
Revolutionizing Cell Therapy Manufacturing: Faster & Safer
🔎 This article explores the challenges in cell therapy manufacturing and the urgency for faster processes. It discusses closed-process systems, bioreactors, and rapid testing methods to improve efficiency. It emphasizes the significance of streamlined manufacturing and quality control testing for faster treatment delivery. The need for a common manufacturing platform and scalability in cell therapy production is also addressed.
Revolutionary Partnership Brings Low-Cost CAR-T Manufacturing to Brazil
🤝 Caring Cross & Fiocruz partner to establish low-cost CAR-T manufacturing in Brazil, reducing costs & providing critical training. 💰🌍🏭👍
